Cargando…

Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion

Increased levels of extracellular superoxide dismutase (ecSOD) induced by preconditioning or gene therapy protect the heart from ischemia/reperfusion injury. To elucidate the mechanism responsible for this action, we studied the effects of increased superoxide scavenging on nitric oxide (NO) bioavai...

Descripción completa

Detalles Bibliográficos
Autores principales: Obal, Detlef, Dai, Shujing, Keith, Rachel, Dimova, Neviana, Kingery, Justin, Zheng, Yu-Ting, Zweier, Jay, Velayutham, Murugesan, Prabhu, Sumanth D., Li, Qianghong, Conklin, Daniel, Yang, Dan, Bhatnagar, Aruni, Bolli, Roberto, Rokosh, Gregg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505528/
https://www.ncbi.nlm.nih.gov/pubmed/23099819
http://dx.doi.org/10.1007/s00395-012-0305-1
_version_ 1782250773808152576
author Obal, Detlef
Dai, Shujing
Keith, Rachel
Dimova, Neviana
Kingery, Justin
Zheng, Yu-Ting
Zweier, Jay
Velayutham, Murugesan
Prabhu, Sumanth D.
Li, Qianghong
Conklin, Daniel
Yang, Dan
Bhatnagar, Aruni
Bolli, Roberto
Rokosh, Gregg
author_facet Obal, Detlef
Dai, Shujing
Keith, Rachel
Dimova, Neviana
Kingery, Justin
Zheng, Yu-Ting
Zweier, Jay
Velayutham, Murugesan
Prabhu, Sumanth D.
Li, Qianghong
Conklin, Daniel
Yang, Dan
Bhatnagar, Aruni
Bolli, Roberto
Rokosh, Gregg
author_sort Obal, Detlef
collection PubMed
description Increased levels of extracellular superoxide dismutase (ecSOD) induced by preconditioning or gene therapy protect the heart from ischemia/reperfusion injury. To elucidate the mechanism responsible for this action, we studied the effects of increased superoxide scavenging on nitric oxide (NO) bioavailability in a cardiac myocyte-specific ecSOD transgenic (Tg) mouse. Results indicated that ecSOD overexpression increased cardiac myocyte-specific ecSOD activity 27.5-fold. Transgenic ecSOD was localized to the sarcolemma and, notably, the cytoplasm of cardiac myocytes. Ischemia/reperfusion injury was attenuated in ecSOD Tg hearts, in which infarct size was decreased and LV functional recovery was improved. Using the ROS spin trap, DMPO, electron paramagnetic resonance (EPR) spectroscopy demonstrated a significant decrease in ROS in Tg hearts during the first 20 min of reperfusion. This decrease in ROS was accompanied by an increase in NO production determined by EPR using the NO spin trap, Fe-MGD. Attenuated ROS in ecSOD Tg myocytes was also supported by decreased production of peroxynitrite (ONOO(−)). Increased NO bioavailability was confirmed by attenuated guanylate cyclase-dependent (p-VASP) signaling. In conclusion, attenuation of ROS levels by cardiac-specific ecSOD overexpression increases NO bioavailability in response to ischemia/reperfusion and protects against reperfusion injury. These findings are the first to demonstrate increased NO bioavailability with attenuation of ROS by direct measurement of these reactive species (EPR, reactive fluorescent dyes) with cardiac-specific ecSOD expression. This is also the first indication that the predominantly extracellular SOD isoform is capable of cytosolic localization that affects myocardial intracellular signal transduction and function. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-012-0305-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3505528
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-35055282012-11-28 Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion Obal, Detlef Dai, Shujing Keith, Rachel Dimova, Neviana Kingery, Justin Zheng, Yu-Ting Zweier, Jay Velayutham, Murugesan Prabhu, Sumanth D. Li, Qianghong Conklin, Daniel Yang, Dan Bhatnagar, Aruni Bolli, Roberto Rokosh, Gregg Basic Res Cardiol Original Contribution Increased levels of extracellular superoxide dismutase (ecSOD) induced by preconditioning or gene therapy protect the heart from ischemia/reperfusion injury. To elucidate the mechanism responsible for this action, we studied the effects of increased superoxide scavenging on nitric oxide (NO) bioavailability in a cardiac myocyte-specific ecSOD transgenic (Tg) mouse. Results indicated that ecSOD overexpression increased cardiac myocyte-specific ecSOD activity 27.5-fold. Transgenic ecSOD was localized to the sarcolemma and, notably, the cytoplasm of cardiac myocytes. Ischemia/reperfusion injury was attenuated in ecSOD Tg hearts, in which infarct size was decreased and LV functional recovery was improved. Using the ROS spin trap, DMPO, electron paramagnetic resonance (EPR) spectroscopy demonstrated a significant decrease in ROS in Tg hearts during the first 20 min of reperfusion. This decrease in ROS was accompanied by an increase in NO production determined by EPR using the NO spin trap, Fe-MGD. Attenuated ROS in ecSOD Tg myocytes was also supported by decreased production of peroxynitrite (ONOO(−)). Increased NO bioavailability was confirmed by attenuated guanylate cyclase-dependent (p-VASP) signaling. In conclusion, attenuation of ROS levels by cardiac-specific ecSOD overexpression increases NO bioavailability in response to ischemia/reperfusion and protects against reperfusion injury. These findings are the first to demonstrate increased NO bioavailability with attenuation of ROS by direct measurement of these reactive species (EPR, reactive fluorescent dyes) with cardiac-specific ecSOD expression. This is also the first indication that the predominantly extracellular SOD isoform is capable of cytosolic localization that affects myocardial intracellular signal transduction and function. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-012-0305-1) contains supplementary material, which is available to authorized users. Springer-Verlag 2012-10-26 2012 /pmc/articles/PMC3505528/ /pubmed/23099819 http://dx.doi.org/10.1007/s00395-012-0305-1 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Contribution
Obal, Detlef
Dai, Shujing
Keith, Rachel
Dimova, Neviana
Kingery, Justin
Zheng, Yu-Ting
Zweier, Jay
Velayutham, Murugesan
Prabhu, Sumanth D.
Li, Qianghong
Conklin, Daniel
Yang, Dan
Bhatnagar, Aruni
Bolli, Roberto
Rokosh, Gregg
Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion
title Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion
title_full Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion
title_fullStr Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion
title_full_unstemmed Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion
title_short Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion
title_sort cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion
topic Original Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505528/
https://www.ncbi.nlm.nih.gov/pubmed/23099819
http://dx.doi.org/10.1007/s00395-012-0305-1
work_keys_str_mv AT obaldetlef cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT daishujing cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT keithrachel cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT dimovaneviana cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT kingeryjustin cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT zhengyuting cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT zweierjay cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT velayuthammurugesan cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT prabhusumanthd cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT liqianghong cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT conklindaniel cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT yangdan cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT bhatnagararuni cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT bolliroberto cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion
AT rokoshgregg cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion